|
As reported, during an intervention involving the external iliac and superficial femoral arteries, an advance 18 lp low profile balloon catheter ruptured.Following placement of another manufacturer's atherectomy device, the device ruptured on the first inflation to eight atmospheres for pre-dilitation prior to stent placement in the external iliac and superficial femoral arteries.The vessels were mildly calcified.A section of the device did not remain inside the patient¿s body.The patient did not require any additional intervention due to this occurrence.The patient did not experience any adverse effects due to this occurrence.Additional event information has been requested.
|
|
Blank fields on this form indicate the information is unknown, unchanged, or unavailable.Summary of event: as reported, during an intervention involving the external iliac and superficial femoral arteries, an advance 18 lp low profile balloon catheter ruptured.Following placement of another manufacturer's atherectomy device, the device ruptured on the first inflation to eight atmospheres for pre-dilatation prior to stent placement in the external iliac and superficial femoral arteries.The vessels were mildly calcified.An inflation device was used with 50/50 contrast to saline solution.Blood was noticed in the inflation device.A new device was used to complete the procedure.A section of the device did not remain inside the patient¿s body.The patient did not require any additional intervention due to this occurrence.The patient did not experience any adverse effects due to this occurrence.Investigation evaluation: reviews of the complaint history, device history record, drawings, instructions for use (ifu), specifications, and quality control procedures were conducted during the investigation.The complaint device was not returned to cook for investigation.A document-based investigation evaluation was performed.There have been no other reported complaints for this lot number.Two related non-conformances were noted on the lot; however, all non-conforming product was scrapped and there are 100% inspections in place to capture this failure mode prior to distribution.The product ifu instructs the user to inspect the product upon removal from the package to ensure no damage has occurred.The device label states that a pta4-18-150-5-20 has a nominal operating pressure of 8 atm/bar and a burst rated pressure of 12 atm/bar, respectively.The information provided upon review of the dmr, dhr, and ifu suggests that there is objective evidence the device was manufactured to specification.There is no evidence of non-conforming devices in-house or in the field.Cook has concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.Based on the information provided and the results of the investigation, cook has concluded that patient anatomy contributed to this incident, as the user reported that the vessels were calcified.The risk analysis for this failure mode was reviewed and no additional escalation was required.The appropriate personnel have been notified and cook will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|